NF-κB-Specific Suppression in Cardiomyocytes Unveils Aging-Associated Responses in Cardiac Tissue

Letícia Aparecida Lopes Morgado1, Larissa Maria Zacarias Rodrigues1, Daiane Cristina Floriano Silva1

  • 1Department of Anatomy, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, Brazil.

Biomedicines
|January 25, 2025
PubMed

Insights

Suppression of Nuclear Factor kappa B (NF-κB) in heart cells accelerates cardiac aging, leading to dysfunction and damage. This highlights NF-κB

Area of Science:

  • Cardiovascular Biology
  • Aging Research
  • Molecular Cardiology

Background:

  • Aging causes heart changes like hypertrophy, fibrosis, and reduced contractility.
  • Cellular mechanisms including senescence and DNA damage contribute to cardiac aging.
  • Nuclear Factor kappa B (NF-κB) is implicated in aging tissues and suspected to regulate cardiac aging.

Purpose of the Study:

  • To investigate the in vivo role of NF-κB in aging-related cardiac alterations.
  • To examine the impact of NF-κB suppression on cardiac senescence and related cellular events.
  • To understand NF-κB's regulatory function in the aging heart.

Main Methods:

  • Used young and old wild-type (WT) and cardiomyocyte-specific NF-κB suppressed (3M) male mice.
  • Assessed cardiac function, morphology, senescence markers, lipofuscin, DNA damage, and apoptosis.
  • Utilized echocardiography and molecular assays for analysis.

Main Results:

  • NF-κB suppression (3M) reduced survival and caused eccentric hypertrophy with diastolic/systolic dysfunction.
  • Both aged WT and 3M mice showed cardiac hypertrophy; 3M mice had more pronounced changes.
  • Fibrosis, senescence markers (β-galactosidase, p21), and DNA damage (p-H2A.X) increased in aged WT and 3M mice.

Conclusions:

  • NF-κB suppression in cardiomyocytes exacerbates cardiac remodeling, dysfunction, and cellular damage during aging.
  • NF-κB plays a critical role in cardiac aging, affecting senescence and DNA damage pathways.
  • Findings suggest therapeutic potential for NF-κB modulation in age-related cardiovascular diseases.